AMG
GSK icon

Advisors Management Group’s GSK GSK Stock Holding History

Advisors Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Sell
59,204
-14,886
-20% -$807K 0.6% 45
2025
Q4 		$3.63M Sell
74,090
-14,434
-16% -$673K 0.66% 44
2025
Q3 		$3.82M Sell
88,524
-1,517
-2% -$59.3K 0.67% 46
2025
Q2 		$3.46M Sell
90,041
-1,145
-1% -$43.8K 0.65% 49
2025
Q1 		$3.53M Sell
91,186
-344
-0.4% -$12.6K 0.77% 41
2024
Q4 		$3.1M Buy
91,530
+5,259
+6% +$189K 0.73% 44
2024
Q3 		$3.53M Buy
86,271
+3,824
+5% +$156K 0.83% 41
2024
Q2 		$3.17M Buy
82,447
+991
+1% +$41.7K 0.79% 41
2024
Q1 		$3.49M Sell
81,456
-766
-0.9% -$31.6K 0.87% 38
2023
Q4 		$3.05M Sell
82,222
-294
-0.4% -$10.6K 0.83% 42
2023
Q3 		$2.99M Buy
82,516
+1,686
+2% +$59.8K 0.9% 41
2023
Q2 		$2.88M Buy
80,830
+2,829
+4% +$101K 0.86% 40
2023
Q1 		$2.77M Buy
78,001
+6,574
+9% +$230K 0.88% 39
2022
Q4 		$2.51M Buy
71,427
+301
+0.4% +$10K 0.95% 40
2022
Q3 		$2.09M Buy
71,126
+17,159
+32% +$650K 0.83% 42
2022
Q2 		$2.94M Sell
53,967
-116
-0.2% -$6.4K 1.03% 36
2022
Q1 		$2.94M Buy
54,083
+21
+0% +$1.14K 1% 38
2021
Q4 		$2.98M Sell
54,062
-239
-0.4% -$12.4K 0.89% 39
2021
Q3 		$2.59M Sell
54,301
-1,106
-2% -$55.6K 0.81% 42
2021
Q2 		$2.76M Sell
55,407
-152
-0.3% -$7.3K 0.82% 43
2021
Q1 		$2.48M Sell
55,559
-573
-1% -$26K 0.78% 45
2020
Q4 		$2.58M Sell
56,132
-242
-0.4% -$11.1K 1.05% 37
2020
Q3 		$2.65M Sell
56,374
-359
-0.6% -$18K 1.1% 35
2020
Q2 		$2.89M Sell
56,733
-1,242
-2% -$63.7K 1.29% 32
2020
Q1 		$2.75M Buy
57,975
+227
+0.4% +$12.1K 1.32% 30
2019
Q4 		$3.39M Sell
57,748
-682
-1% -$37.9K 1.35% 32
2019
Q3 		$3.12M Sell
58,430
-417
-0.7% -$21.5K 1.29% 32
2019
Q2 		$2.94M Sell
58,847
-600
-1% -$30.1K 1.28% 36
2019
Q1 		$3.1M Buy
59,447
+279
+0.5% +$13.9K 1.39% 32
2018
Q4 		$2.83M Sell
59,168
-850
-1% -$41.9K 1.49% 32
2018
Q3 		$3.01M Sell
60,018
-312
-0.5% -$15.9K 1.38% 35
2018
Q2 		$3.04M Sell
60,330
-306
-0.5% -$15.4K 1.45% 34
2018
Q1 		$2.98M Sell
60,636
-335
-0.5% -$15.6K 1.53% 30
2017
Q4 		$2.7M Buy
60,971
+739
+1% +$34.1K 1.39% 31
2017
Q3 		$3.06M Buy
60,232
+943
+2% +$47.8K 1.62% 28
2017
Q2 		$3.2M Buy
59,289
+936
+2% +$49.9K 1.76% 22
2017
Q1 		$3.08M Buy
58,353
+4,373
+8% +$222K 1.94% 22
2016
Q4 		$2.6M Sell
53,980
-124
-0.2% -$6.13K 1.76% 29
2016
Q3 		$2.92M Sell
54,104
-476
-0.9% -$26.1K 1.94% 21
2016
Q2 		$2.96M Sell
54,580
-252
-0.5% -$13.3K 2.06% 19
2016
Q1 		$2.78M Sell
54,832
-104
-0.2% -$5.18K 2.03% 18
2015
Q4 		$2.77M Buy
+54,936
New +$2.8M 2.27% 14

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisors Management Group's GSK Position: Q1 2026 in Review

Advisors Management Group reduced its GSK (GSK) stake by 20% in Q1 2026, selling an estimated $807K and leaving 59,204 shares worth $3.27M. The position accounts for 0.6% of the portfolio, ranked #45.

Advisors Management Group first reported a position in GSK in Q4 2015 and has held it in 42 quarters since. The position peaked at $3.82M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Advisors Management Group held 59,204 shares of GSK worth $3.27M as of Q1 2026.
  • Advisors Management Group sold 14,886 GSK shares in Q1 2026, an estimated $807K.
  • GSK made up 0.6% of Advisors Management Group's portfolio in Q1 2026, its #45 holding.
  • Advisors Management Group first reported a position in GSK in Q4 2015 and has held it in 42 quarters since.
  • Advisors Management Group's GSK position peaked at $3.82M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.